Company · CIK 1662244
Cyteir Therapeutics, Inc.
| CIK | 1662244 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-08-09 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-266676 | 2022-08-08 | 2024-03-13 | 3 | |
| 333-256601 | 2021-05-28 | 2021-06-21 | 5 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-03-13 | EFFECTDeclared effective | 333-266676 | 9999999995-24-000651 |
| 2022-08-16 | EFFECTDeclared effective | 333-266676 | 9999999995-22-002401 |
| 2022-08-08 | S-3Shelf registered | 333-266676 | 0001193125-22-215095 |
| 2021-06-21 | 424B4Final prospectus | 333-256601 | 0001193125-21-194049 |
| 2021-06-17 | EFFECTDeclared effective | 333-256601 | 9999999995-21-002394 |
| 2021-06-14 | S-1/AAmendment | 333-256601 | 0001193125-21-189385 |
| 2021-06-04 | S-1/AAmendment | 333-256601 | 0001193125-21-182985 |
| 2021-05-28 | S-1Registration filed | 333-256601 | 0001193125-21-176892 |
| 2021-03-26 | DRSDraft made public | 377-04521 | 0000950123-21-003927 |